Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2012; 18(39): 5581-5588
Published online Oct 21, 2012. doi: 10.3748/wjg.v18.i39.5581
Published online Oct 21, 2012. doi: 10.3748/wjg.v18.i39.5581
Table 2 Prognoses of stage III gastric cancer patients according to the thioredoxin and thioredoxin-interacting protein gene expression levels
| Group | Mean RFS,(95% CI), mo | 3-yr recurrenc-e-free rate (%) | 5-yr surviv-al rate (%) |
| 1: Low TXN and high TXNIP | Non applicable | 70 | 89 |
| 2: Neither group 1 nor group 3 | 36.7 (15.5-57.9) | 51 | 73 |
| 3: High TXN and low TXNIP | 11.9 (9.5-14.2) | 7 | 29 |
| P value by log rank test | P < 0.001 | P = 0.001 |
- Citation: Lim JY, Yoon SO, Hong SW, Kim JW, Choi SH, Cho JY. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence. World J Gastroenterol 2012; 18(39): 5581-5588
- URL: https://www.wjgnet.com/1007-9327/full/v18/i39/5581.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i39.5581